Protocol: CDISCPILOT01                                                                  Page  1 of 1 
Population: Efficacy 
Table 14-3.11 
ADAS Cog (11) - Repeated Measures Analysis of Change from Baseline to Week 24 
 
 
Note: The change from baseline is calculated as the post-baseline score minus the baseline score. The 
covariates included in the MMRM model are treatment, site group, time and treatment by time interaction, 
baseline ADAS-Cog (11) score, and baseline ADAS-Cog (11) score by time interaction. 
Source: C:\cdisc_pilot\PROGRAMS\DRAFT\TFLs\rtf_eff_mmrm.sas              21:06 Monday, June 26, 2006 
 
Placebo 
 (N=79)  
Xanomeline 
 Low Dose 
 (N=81)  
Xanomeline 
 High Dose 
 (N=74)  
 
LS Means (SE)               
   1.6 (0.49) 
   1.5 (0.52) 
   1.1 (0.56) 
 
p-value(Xan - Placebo)      
 
   0.955 
   0.556 
 Diff of LS Means (SE)      
 
-0.0 (0.70) 
-0.4 (0.72) 
 95% CI                     
 
(-1.4;1.3) 
(-1.9;1.0) 
 
p-value(Xan High - Xan Low) 
 
 
   0.606 
 Diff of LS Means (SE)      
 
 
-0.4 (0.75) 
 95% CI                     
 
 
(-1.9;1.1) 
 
